A Comprehensive Analysis of Hungarian MODY Patients-Part I: Gene Panel Sequencing Reveals Pathogenic Mutations in HNF1A, HNF1B, HNF4A, ABCC8 and INS Genes

被引:7
|
作者
Gaal, Zsolt [1 ]
Szucs, Zsuzsanna [2 ]
Kantor, Iren [3 ]
Luczay, Andrea [4 ]
Toth-Heyn, Peter [4 ]
Benn, Orsolya [5 ]
Felszeghy, Eniko [6 ]
Karadi, Zsuzsanna [5 ]
Madar, Laszlo [2 ]
Balogh, Istvan [2 ]
机构
[1] Josa Andras Teaching Hosp, Dept Med 4, H-4400 Nyiregyhaza, Hungary
[2] Univ Debrecen, Fac Med, Dept Lab Med, Div Clin Genet, H-4032 Debrecen, Hungary
[3] Josa Andras Teaching Hosp, Dept Pediat, H-4400 Nyiregyhaza, Hungary
[4] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary
[5] Szent Gyorgy Hosp Fejer Cty, Dept Pediat, H-8000 Szekesfehervar, Hungary
[6] Univ Debrecen, Fac Med, Dept Pediat, H-4032 Debrecen, Hungary
来源
LIFE-BASEL | 2021年 / 11卷 / 08期
关键词
MODY; monogenic diabetes; HNF1A; transcription factor MODY; next-generation sequencing; NGS; Hungary; NUCLEAR FACTOR-1-ALPHA GENE; PANCREATIC BETA-CELLS; ALPHA-GENE; DIABETES-MELLITUS; ONSET; YOUNG; DIAGNOSIS; FAMILIES; HETEROGENEITY; PREVALENCE;
D O I
10.3390/life11080755
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Maturity-onset diabetes of the young (MODY) has about a dozen known causal genes to date, the most common ones being HNF1A, HNF4A, HNF1B and GCK. The phenotype of this clinically and genetically heterogeneous form of diabetes depends on the gene in which the patient has the mutation. We have tested 450 Hungarian index patients with suspected MODY diagnosis with Sanger sequencing and next-generation sequencing and found a roughly 30% positivity rate. More than 70% of disease-causing mutations were found in the GCK gene, about 20% in the HNF1A gene and less than 10% in other MODY-causing genes. We found 8 pathogenic and 9 likely pathogenic mutations in the HNF1A gene in a total of 48 patients and family members. In the case of HNF1A-MODY, the recommended first-line treatment is low dose sulfonylurea but according to our data, the majority of our patients had been on unnecessary insulin therapy at the time of requesting their genetic testing. Our data highlights the importance of genetic testing in the diagnosis of MODY and the establishment of the MODY subtype in order to choose the most appropriate treatment.
引用
收藏
页数:13
相关论文
共 18 条
  • [1] Lack of mutations of HNF1A genes, HNF4A and INS in ten Tunisian patients with MODY type diabetes
    Amara, A.
    Ghezail, H.
    Brahem, R.
    Gribaa, M.
    Philippe, J.
    Dechaume, A.
    Saad, A.
    Chadli-Chaieb, M.
    Chaieb, L.
    Froguel, P.
    Vaxillaire, M.
    DIABETES & METABOLISM, 2011, 37 : A64 - A65
  • [2] MODY genes HNF1A, GCK and HNF4A pathogenic variant spectrum in pediatric patients
    Sukys, M.
    Asmoniene, V.
    Traberg, R.
    Cereskevicius, D.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1262 - 1263
  • [3] Species-Specific Differences in the Expression of the HNF1A, HNF1B and HNF4A Genes
    Harries, Lorna W.
    Brown, James E.
    Gloyn, Anna L.
    PLOS ONE, 2009, 4 (11):
  • [4] GCK, HNF1A and HNF4A variant analysis in suspected MODY patients
    Zemeckiene, Zivile
    Sukys, Marius
    Jonikas, Rimvydas
    Nasvytiene, Inga
    Valanciute, Inga
    Poceviciene, Inga
    Ugenskiene, Rasa
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 148 - 149
  • [5] A large part of the MODY patients in Slovakia do not have any mutation in GCK, HNF1A, HNF4A, HNF1B, KCNJ11 or insulin genes
    Gasperikova, D.
    Stanik, J.
    Huckova, M.
    Valentinova, L.
    Masindova, I.
    Lesayova, D.
    Barak, L.
    Kusekova, M.
    Sandrikova, V.
    Javorkova, J.
    Michalek, J.
    Klimes, I.
    DIABETOLOGIA, 2010, 53 : S116 - S117
  • [6] Novel Presentations of Congenital Hyperinsulinism due to Mutations in the MODY genes: HNF1A and HNF4A
    Stanescu, Diana E.
    Hughes, Nkecha
    Kaplan, Bernard
    Stanley, Charles A.
    De Leon, Diva D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : E2026 - E2030
  • [7] Mutation spectrum of GCK, HNF1A and HNF1B in MODY patients and 40 novel mutations
    Ozkinay, F.
    Isik, E.
    Simsek, D. G.
    Aykut, A.
    Karaca, E.
    Ozen, S.
    Bolat, H.
    Atik, T.
    Saygili, F.
    Kartal, E.
    Gul, U.
    Anik, A.
    Tutunculer, F.
    Eren, E.
    Ozbek, M. N.
    Bober, E.
    Abaci, A.
    Kirel, B.
    Ersoy, B.
    Buyukinan, M.
    Kara, C.
    Cakir, E. P.
    Yildirim, R.
    Isguven, P.
    Dagdeviren, A.
    Agladioglu, S. Y.
    Dogan, M.
    Sangun, O.
    Arslanoglu, I.
    Korkmaz, H. A.
    Temiz, F.
    Onay, H.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 208 - 209
  • [8] Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes
    Forlani, Gabriele
    Zucchini, Stefano
    Di Rocco, Antonio
    Di Luzio, Raffaella
    Scipione, Mirella
    Marasco, Elena
    Romeo, Giovanni
    Marchesini, Giulio
    Mantovani, Vilma
    DIABETES CARE, 2010, 33 (11) : 2336 - 2338
  • [9] Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database
    Warncke, Katharina
    Kummer, Sebastian
    Raile, Klemens
    Grulich-Henn, Juergen
    Woelfle, Joachim
    Steichen, Elisabeth
    Prinz, Nicole
    Holl, Reinhard W.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (03): : 845 - 855
  • [10] Whole gene deletion mutation of HNF1B and exonic aberration mutations of GCK and HNF1B in patients with MODY in Japan
    Takizawa, Miho
    Iwasaki, Naoko
    Yamamoto, Toshiyuki
    Uchigata, Yasuko
    Iwamoto, Yasuhiko
    DIABETOLOGY INTERNATIONAL, 2012, 3 (04) : 224 - 232